Market Quotes

5546 items in section

U.S. Crude Inventories Expected to Shrink for Third Straight Week

Refineries across the United States are maintaining a high-tempo pace, driving expectations of a 1.4 million-barrel drawdown in commercial crude oil stockpiles for the week ending September 11. Market participants anticipate this third consecutive decline as demand remains firm ahead of official data due Wednesday morning.

Gias Foods Recalls Bettergoods Fettuccine Over Listeria Concerns

Two specific production lots of Bettergoods-branded Lemon Alfredo Fettuccine are being pulled from Walmart shelves after routine state safety inspections flagged potential listeria contamination. While the recall covers thousands of units, health officials confirm that no consumers have reported illnesses linked to the product as of this morning.

Forward Industries Dips as SkyAI Acquisition Bid Returns

Investors pushed Forward Industries shares down 9% to $6.33 Tuesday following a renewed attempt to acquire SkyAI. The offer, priced at $2.13 per share, marks a 50% premium over Monday’s closing values, yet the market response suggests skepticism regarding the company's aggressive pursuit of the Solana treasury firm.

Alfonso Barco Muñoz Steps In as Acting CEO of Ecopetrol

The leadership transition at Colombia’s state-controlled oil giant hit a milestone this Tuesday as Alfonso Camilo Barco Muñoz assumed the role of acting chief executive officer. He steps into the position following the departure of Juan Carlos Hurtado Parra, marking the final stage of a succession plan finalized this past July.

Thatch Hits Unicorn Status With $108 Million Series C

A $108 million capital injection has propelled health-benefits startup Thatch to a $1 billion valuation. The Series C round, backed by major venture firms and industry incumbents, signals intensifying investor appetite for platforms that decentralize corporate health coverage by shifting purchasing power directly to individual employees.

Factory Reaches $5 Billion Valuation Following $200 Million Funding

With a fresh $200 million injection, the AI software developer Factory has seen its valuation surge to $5 billion in just seven months. The company, which builds autonomous systems for corporate coding, has now secured over $400 million in total capital to accelerate its platform development for enterprise clients.

Bank of Montreal Backs $1 Billion Radical Ventures AI Fund

With over US$1 billion in institutional commitments, the new Radical Breakouts fund is positioning itself to scale late-stage artificial intelligence startups into global market leaders. The strategy, launched by Toronto-based Radical Ventures, marks a significant push to bridge the capital gap for maturing technology companies in Canada and beyond.

RB Global Doubles Share Buyback Capacity to $1 Billion

Investors pushed RB Global shares higher Tuesday after the company secured regulatory approval to double its share-repurchase program to $1 billion. This aggressive expansion of capital return signals management’s intent to stabilize stock performance following a difficult start to the year that saw the company’s value slide by 16%.

Canada Opens Major Airports to Pension Fund Investment

Prime Minister Mark Carney announced Tuesday that Canada will transition its four largest airports to private-sector operational control. By inviting institutional investors to manage these hubs through long-term concessions, the government aims to catalyze domestic capital for national infrastructure projects and reduce economic dependency on the United States.

Crypto Equities Retreat as Senate Prepares for Clarity Act Vote

A cloud of uncertainty hangs over the digital asset sector as investors retreat ahead of a pivotal Senate procedural vote on the Clarity Act. While the legislation promises a foundational regulatory framework for the industry, conflicting views regarding ethics provisions have tempered market enthusiasm, triggering a broad sell-off across major crypto-linked stocks.

Axon Shares Slide on $1 Billion Convertible Debt Offering

Axon Enterprise shares tumbled 10% on Tuesday morning to $438.87 after the company announced a $1 billion public offering of convertible senior notes due in 2031. The move, which aims to fuel future acquisitions and corporate growth, marks a significant shift for the firm as it navigates a 42% decline over the past year.

Evertz Technologies Profit Slides as Operational Costs Climb

Investors pushed Evertz Technologies shares down 9.1% to 13.50 Canadian dollars on Tuesday after the video network firm missed quarterly earnings expectations. Despite a healthy climb in total revenue, rising administrative expenses and R&D spending eroded the company's bottom line, leaving profit well below analyst projections.

Origin Bancorp Shifts Primary Listing to Texas Stock Exchange

In a move signaling a shift in regional financial infrastructure, Origin Bancorp will depart the New York Stock Exchange to become one of the inaugural companies on the Texas Stock Exchange. The bank holding company confirmed on Tuesday that it will finalize the transition on October 13 while retaining its OBK ticker.

Canada Shifts Strategy to Open Major Airports to Pension Fund Capital

Prime Minister Mark Carney announced on Tuesday that Canada is prepared to transfer operations of its four largest airports to institutional investors. This pivot aims to unlock billions for national infrastructure projects, including critical trade corridors, while simultaneously diversifying the economy to reduce dependence on a protectionist United States.

Cindy Yao Joins Tredegar as Finance Chief

Richmond-based industrial manufacturer Tredegar has tapped Cindy Yao to serve as its new vice president, chief financial officer, and treasurer. Yao, who currently oversees finances at healthcare provider Holon Health, steps into the role on September 21, succeeding Frasier Brickhouse II following his retirement earlier this month.

WhiteHorse Finance Weighs Potential Sale Amid Strategic Review

The board of WhiteHorse Finance has officially launched an exploration of strategic alternatives, opening the door to a potential sale of the company. Independent directors have formed a special committee to oversee the process, signaling a pivotal shift in direction for the business development firm as it evaluates its future.

DoorDash Bets $125M on Wonder to Secure Campus Dining Foothold

DoorDash is pouring $125 million into Wonder, the parent company of rival Grubhub, in a strategic maneuver to dominate institutional food services. Alongside this investment, the delivery giant reached a $300 million agreement to acquire the Grubhub campus dining division, signaling a major pivot toward closed-loop venues like stadiums and hotels.

Grupa Kety Shares Surge 10% Following 645 Million Euro Acquisition

Shares in Polish aluminum manufacturer Grupa Kety climbed 9.9% to 1,266 zloty on Tuesday, securing the top spot among Stoxx 600 risers. The rally follows the company's announcement of a 645 million euro deal to acquire Fengari Holdings, a strategic move intended to accelerate its international expansion.

Canada Pivots Toward Europe in Strategic Economic Realignment

Prime Minister Mark Carney is launching formal negotiations with the European Union next month to establish a comprehensive security and economic alliance. This move marks a decisive effort by Ottawa to diversify its international partnerships as the country seeks to lessen its long-standing economic dependence on the United States.

Enova Shares Slide After Abandoning Grasshopper Bancorp Acquisition

A 17.7% plunge in Enova International’s stock price followed the company’s surprise decision to withdraw its regulatory applications for the $369 million acquisition of Grasshopper Bancorp. The retreat marks a sudden end to the cash-and-stock deal announced just last December, spooking investors in pre-market trading Tuesday.

Rocket Pharma Rallies as FDA Clears Path for Danon Disease Trial

A 5.1% premarket surge pushed Rocket Pharmaceuticals shares to $3.60 after regulators signaled approval for the company’s pivotal phase 2 trial. The FDA review confirmed that the study of RP-A501, a treatment for the rare genetic condition Danon disease, may proceed under a modified clinical protocol.

Sharon Price John Pivots Carter’s Toward a New Brand Identity

After a 13-year tenure revitalizing Build-A-Bear Workshop, CEO Sharon Price John is turning her focus to the struggling apparel retailer Carter’s, launching a brand promise centered on child support and a refreshed visual identity to stabilize the company’s position in a tightening retail market.

Vera Bradley Returns to Profitability Amid Revenue Gains

A 12% surge in premarket trading followed Vera Bradley’s report of a $4.5 million profit for the fiscal second quarter. The handbag retailer successfully reversed its year-ago loss of $4.67 million, fueled by a 1.1% revenue increase to $71.6 million as its business transformation efforts gain traction.

Judy Marks to Step Down as Otis CEO by 2027

After leading the elevator and escalator giant through its transition as an independent public company, Judy Marks will step down from her roles as board chair, president, and chief executive by July 2027, marking the end of a tenure that began when she joined the firm in 2017.

Torm Shares Retreat as Oaktree Unit Offloads $290 Million Stake

A 6.5% premarket slide hit Torm shares Tuesday after OCM Njord Holdings, an affiliate of Oaktree Capital Management, moved to divest a significant portion of its position. The secondary offering of 9 million class A shares is set to generate roughly $290.3 million for the investment firm.

Forgent Power Solutions Climbs as Quarterly Earnings Beat Expectations

Forgent Power Solutions shares jumped 8% to $30.94 in premarket trading Tuesday after the electrical-distribution equipment maker reported quarterly results that outperformed Wall Street forecasts. The company’s pivot to profitability and an optimistic full-year outlook signaled a sharp reversal for a stock that had tumbled 53% over the last three months.

Vera Therapeutics Stock Surges on Successful Kidney Drug Trial

A 9.8% jump in premarket trading greeted Vera Therapeutics on Tuesday after the company reported that its flagship treatment, Trutakna, met all primary goals in a late-stage clinical trial for patients suffering from primary IgA nephropathy, a progressive autoimmune condition that frequently leads to kidney failure.

CareRx Clears Path for C$5.7 Million Share Buyback

Toronto Stock Exchange regulators have authorized CareRx to launch a fresh share repurchase program, allowing the pharmacy services provider to cancel up to 2.75% of its public float. The move comes as the company seeks to stabilize its equity following a 15% slide in market valuation since January.

Waystar Shares Rally on Potential Buyout Rumors

Investors pushed Waystar stock up 16% in Tuesday's premarket trading to $28.81 after reports emerged that the healthcare software firm is weighing a potential sale. The surge marks a sharp reversal for the company, which saw its share value plummet by roughly 24% since the start of the year.

Lindblad Expeditions Lifts Financial Forecast After Antarctica Deal

Lindblad Expeditions Holdings has raised its full-year guidance, projecting tour revenues between $850 million and $880 million. The upward revision follows the company’s $61 million acquisition of a majority stake in White Desert and the aviation brand Echo Charlie, marking the largest transaction in the travel firm's history.